CR Double-Crane to be the largest shareholder of Second Pharma

Summary: In late September, CR Double-Crane announced that its wholly-owned subsidiary, CR Saike, intended to put 82.52% stake in Second Pharma to the account of CR Double-Crane. And the deal had been considered and approved by the board of directors...

Vitamins China E-News 201910

www.cnchemicals.com